Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct 9:6:284.
doi: 10.3389/fped.2018.00284. eCollection 2018.

The Vasculopathy of Juvenile Dermatomyositis

Affiliations
Review

The Vasculopathy of Juvenile Dermatomyositis

Charalampia Papadopoulou et al. Front Pediatr. .

Abstract

Juvenile dermatomyositis (JDM) is a rare autoimmune disease mainly characterized by muscle and skin involvement. Vasculopathy is considered central to the pathogenesis of the disease. The exact nature of vasculopathy is not yet understood but it is a complex process with both an inflammatory and a non-inflammatory, occlusive component. Impaired function of JDM vasculature includes immune complex deposition, altered expression of cell adhesion molecules predominantly inducing Th17 cell infiltration, and endothelial cell dysfunction. Development of vasculopathy is associated with the severe extra-muscular manifestations of JDM, such as gastrointestinal and cardiac manifestations, interstitial lung disease, ulcerative skin disease or development of calcinosis, and portends a poor prognosis. Correlation of histopathological findings, autoantibodies, and extensive diagnostic workup represent key elements to the early detection of vasculopathic features and early aggressive treatment. Monitoring of vasculopathy remains challenging due to the lack of non-invasive biomarkers. Current treatment approaches provide variable benefit, but better understanding of the essential pathogenic mechanisms should help lead to improved outcomes. Whilst acknowledging that evidence is limited, this review aims to describe the vasculopathy of JDM in the context of pathophysiology, clinical features, and treatment of disease.

Keywords: Juvenile; antibodies; dermatomyositis; pathophysiology; vasculopathy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Muscle biopsy findings in a patient with JDM. (A) Haematoxylin and eosin (H&E) stain showing vessel endothelial swelling. (B) Immunohistochemical staining for membrane attack complex (MAC) showing deposition on muscle capillaries. Magnification 40x.
Figure 2
Figure 2
Skin changes seen in juvenile dermatomyositis. (A) Heliotrope rash – erythema involving both upper eyelids in a patient with JDM. Written informed parent consent was obtained for the publication of this image. (B) Gottron's papules over metacarpal and interphalangeal joints with linear extensor erythema. (C) Palmar vasculopathy- palmar erythema, most prominent over the joint creases.

Similar articles

Cited by

References

    1. Wu Q, Wedderburn LR, McCann LJ. Juvenile dermatomyositis: latest advances. Best Prac Res Clin Rheumatol. (2017) 31:535–57. 10.1016/j.berh.2017.12.003 - DOI - PubMed
    1. Meyer A, Meyer N, Schaeffer M, Gottenberg JE, Geny B, Sibilia J. Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology. (2015) 54:50–63. 10.1093/rheumatology/keu289 - DOI - PubMed
    1. Wedderburn LR, Rider LG. Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment. Best Pract Res Clin Rheumatol. (2009) 23:665–78. 10.1016/j.berh.2009.07.007 - DOI - PMC - PubMed
    1. Whitaker JN, Engel WK. Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy. N Engl J Med. (1972) 286:333–8. 10.1056/NEJM197202172860701 - DOI - PubMed
    1. Crowe WE, Bove KE, Levinson JE, Hilton PK. Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis. Arthr Rheum. (1982) 25:126–39. 10.1002/art.1780250203 - DOI - PubMed

LinkOut - more resources